Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
about
Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal InjuryTripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic RatsArginase inhibition: a new treatment for preventing progression of established diabetic nephropathyAnthocyanins inhibit high-glucose-induced cholesterol accumulation and inflammation by activating LXRα pathway in HK-2 cellsXiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signalingCorosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damageProteinuria in systemic sclerosis: reversal by ACE inhibitionProtective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.Effects of zishentongluo in patients with early-stage diabetic nephropathy.Distinct roles of arginases 1 and 2 in diabetic nephropathy.Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
P2860
Q26777994-AABDF2B0-FCCB-43B9-AC9A-D1E9AB4128C8Q30423005-809DF912-1AEF-44B8-B26D-851EC0D4F9C3Q35710293-1248CC02-0492-42E2-89DF-00841E3775A9Q35996116-44AB122E-C6C7-4EE1-85B9-8F7B3448DB5AQ36017619-B52D8264-DF00-42BA-A1CA-FCE06F0B2B7BQ36052340-60F4BCC7-DBF7-44F4-8F39-A22F141E4F02Q36347812-2ADB4DD1-C92C-41B3-820D-6CABF58B42B6Q36941304-0EFF7C26-E8D4-4094-A087-A383E24B94F8Q37115067-58F8D17A-CEA3-4002-9045-D9EEC9705074Q37142636-38EB196E-C857-4D39-B824-DA32216E8074Q41559116-779D5032-77A2-45C1-9951-8919959513F7Q43851488-6452904B-8570-4D7E-892F-48D89867DAFBQ51033386-EE585D4E-8D77-4E55-9276-862BB80CA4D8Q51282432-6F007C77-8600-4F00-99BF-E7635FC8D13D
P2860
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches
@nl
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
@ast
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
@en
type
label
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches
@nl
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
@ast
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
@en
prefLabel
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches
@nl
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
@ast
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
@en
P2093
P2860
P3181
P1476
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches
@en
P2093
Alaa S Awad
Emaad M Abdel-Rahman
Lawand Saadulla
P2860
P2888
P304
P3181
P356
10.1007/S11606-011-1912-5
P407
P50
P577
2011-10-18T00:00:00Z
P5875
P6179
1045767789